Related Experiment Videos
Lexipafant inhibits postsurgical adhesion formation
Hedef Ozgün1, Mehmet Hakan Cevikel, Leyla Didem Kozaci
1Department of Surgery, Adnan Menderes University, Aydin, Turkey.
Insights
Lexipafant, a platelet activating factor antagonist, effectively prevents peritoneal adhesion formation. This study found no significant impact on wound healing, suggesting its therapeutic potential in inflammatory conditions.
Area of Science:
- Biomedical research
- Inflammation and immunology
Background:
- Platelet-activating factor (PAF) antagonists are explored for inflammatory conditions.
- Lexipafant's role in peritoneal adhesion and wound healing requires investigation.
Purpose of the Study:
- To evaluate the efficacy of lexipafant in preventing peritoneal adhesion formation.
- To assess the effect of lexipafant on wound healing processes.
Main Methods:
- 48 Wistar albino rats were divided into four groups: adhesion-induced lexipafant, adhesion-induced saline, sham-operated lexipafant, and sham-operated saline.
- Peritoneal adhesions were induced via uterine horn scraping; lexipafant or saline was administered.
- Adhesion scoring, hydroxyproline content, and serum IL-6 levels were assessed on day 14.
Main Results:
- Adhesion scores were significantly lower in the lexipafant-treated group compared to saline controls (P < 0.001).
- Serum IL-6 levels were elevated in the saline-treated adhesion group (P < 0.05).
- Hydroxyproline content showed no significant differences across groups.
Conclusions:
- Lexipafant demonstrates a significant role in preventing peritoneal adhesion formation.
- The administration of lexipafant did not adversely affect wound healing in this model.
Background:
PAF and its antagonists have been studied in the pathophysiology of various inflammatory conditions. This study investigates the effects of a platelet activating factor antagonist, lexipafant, on peritoneal adhesion formation and wound healing.
Materials And Methods:
Forty-eight Wistar albino rats (300-350 g) were divided into four equal groups; adhesion-induced lexipafant (AL), adhesion-induced saline (AS), sham-operated lexipafant (SL), and sham-operated saline (SS). All rats underwent a midline laparotomy under sterile conditions. The anterior wall of the left uterine horn was scraped to cause hemorrhages in adhesion-induced groups. Following peritoneal injections of either saline or lexipafant, the incisions were closed in layers. On the 14th day, the rats were killed and adhesions were scored from 0 (none) to 4 (dense). Tissue samples from the adhesions and the left horn of uterus were examined biochemically for hydroxyproline content, and serum IL-6 levels were determined.
Results:
The adhesion formation score was significantly increased in the AS group compared to the SL and AL groups (P < 0.001). The IL-6 levels of the AS group were higher than those of the other groups (P < 0.05). There was no significant difference in hydroxyproline content between groups (P > 0.05).
Conclusions:
Lexipafant plays a role in the prevention of adhesion formation without affecting wound healing.